Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1993 Mar;35(3):299–301. doi: 10.1111/j.1365-2125.1993.tb05697.x

Haemodynamic and hormonal responses to oral enalapril in salt depleted normotensive man.

R J MacFadyen 1, H L Elliott 1, P A Meredith 1, J L Reid 1
PMCID: PMC1381578  PMID: 8471406

Abstract

A combination of dietary sodium restriction (40 mmol day-1) and frusemide pretreatment has been used to activate the renin angiotensin system (RAS) in order to characterise the haemodynamic and hormonal responses to enalapril in young normotensives. Enalapril significantly reduced supine blood pressure with a mean maximum fall of 19 +/- 7.6, compared with 6.5 +/- 6.8 mm Hg with placebo. Similar but greater responses were seen in erect blood pressure. Mean maximal plasma ACE inhibition (78 +/- 5.7%) was associated with a significant increase in PRA from 5.2 +/- 2.1 ngAI ml-1 h-1 to a peak of 29.1 +/- 6 ngAI ml-1 h-1. This simple well tolerated regimen produced consistent RAS activation and gave readily measurable falls in blood pressure following enalapril. This model may be used to undertake detailed assessments of ACE inhibition, renin inhibition and angiotensin receptor blockade.

Full text

PDF
299

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anand I. S., Ferrari R., Kalra G. S., Wahi P. L., Poole-Wilson P. A., Harris P. C. Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation. 1989 Aug;80(2):299–305. doi: 10.1161/01.cir.80.2.299. [DOI] [PubMed] [Google Scholar]
  2. Braunwald E. ACE inhibitors--a cornerstone of the treatment of heart failure. N Engl J Med. 1991 Aug 1;325(5):351–353. doi: 10.1056/NEJM199108013250508. [DOI] [PubMed] [Google Scholar]
  3. Derkx F. H., Tan-Tjiong H. L., Man in 't Veld A. J., Schalekamp M. P., Schalekamp M. A. Activation of inactive plasma renin by plasma and tissue kallikreins. Clin Sci (Lond) 1979 Oct;57(4):351–357. doi: 10.1042/cs0570351. [DOI] [PubMed] [Google Scholar]
  4. EDMONDS C. J., WILSON G. M. The action of hydroflumethiazide in relation to adrenal steroids and potassium loss. Lancet. 1960 Mar 5;1(7123):505–509. doi: 10.1016/s0140-6736(60)90447-5. [DOI] [PubMed] [Google Scholar]
  5. Hodsman G. P., Isles C. G., Murray G. D., Usherwood T. P., Webb D. J., Robertson J. I. Factors related to first dose hypotensive effect of captopril: prediction and treatment. Br Med J (Clin Res Ed) 1983 Mar 12;286(6368):832–834. doi: 10.1136/bmj.286.6368.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hollenberg N. K., Meggs L. G., Williams G. H., Katz J., Garnic J. D., Harrington D. P. Sodium intake and renal responses to captopril in normal man and in essential hypertension. Kidney Int. 1981 Aug;20(2):240–245. doi: 10.1038/ki.1981.126. [DOI] [PubMed] [Google Scholar]
  7. Johnston G. D., Nicholls D. P., Leahey W. J. The dose-response characteristics of the acute non-diuretic peripheral vascular effects of frusemide in normal subjects. Br J Clin Pharmacol. 1984 Jul;18(1):75–81. doi: 10.1111/j.1365-2125.1984.tb05024.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kiowski W., Linder L., Kleinbloesem C., van Brummelen P., Bühler F. R. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition. Circulation. 1992 Jan;85(1):1–8. doi: 10.1161/01.cir.85.1.1. [DOI] [PubMed] [Google Scholar]
  9. Levine D., Ramsay L., Auty R., Branch R., Tidd M. Antagonism of endogenous mineralocorticoids in normal subjects by prorenoate potassium and spironolactone. Eur J Clin Pharmacol. 1976 Mar 22;09(5-6):381–386. doi: 10.1007/BF00606552. [DOI] [PubMed] [Google Scholar]
  10. MacFadyen R. J., Lees K. R., Reid J. L. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study. Br Heart J. 1991 Sep;66(3):206–211. doi: 10.1136/hrt.66.3.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. MacFadyen R. J., Lees K. R., Reid J. L. Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs. Br J Clin Pharmacol. 1991 Jan;31(1):1–13. doi: 10.1111/j.1365-2125.1991.tb03851.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Tocco D. J., deLuna F. A., Duncan A. E., Vassil T. C., Ulm E. H. The physiological disposition and metabolism of enalapril maleate in laboratory animals. Drug Metab Dispos. 1982 Jan-Feb;10(1):15–19. [PubMed] [Google Scholar]
  13. Tuck M. L., Sambhi M. P., Kramer S. B., Eggena P., Barrett J. Enhanced renin levels after discontinuation of furosemide: additional effects of loop diuretics on renin release. Clin Exp Hypertens A. 1982;4(8):1359–1375. doi: 10.3109/10641968209060795. [DOI] [PubMed] [Google Scholar]
  14. Williams G. H. Converting-enzyme inhibitors in the treatment of hypertension. N Engl J Med. 1988 Dec 8;319(23):1517–1525. doi: 10.1056/NEJM198812083192305. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES